131 related articles for article (PubMed ID: 11019604)
1. Tamoxifen effects on endometrium.
Colacurci N; De Seta L; De Franciscis P; Mele D; Fortunato N; Cassese S
Panminerva Med; 2000 Mar; 42(1):45-7. PubMed ID: 11019604
[TBL] [Abstract][Full Text] [Related]
2. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
3. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.
Schwartz LB; Snyder J; Horan C; Porges RF; Nachtigall LE; Goldstein SR
Ultrasound Obstet Gynecol; 1998 Jan; 11(1):48-53. PubMed ID: 9511196
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of endometrial proliferation in pipelle biopsies in tamoxifen-treated postmenopausal women with breast cancer in Kuwait.
Al-Azemi M; Labib NS; Motawy MM; Temmim L; Moussa MA; Omu AE
Med Princ Pract; 2004; 13(1):30-4. PubMed ID: 14657616
[TBL] [Abstract][Full Text] [Related]
5. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
Lahti E; Blanco G; Kauppila A; Apaja-Sarkkinen M; Taskinen PJ; Laatikainen T
Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
[TBL] [Abstract][Full Text] [Related]
6. The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.
Powles TJ; Bourne T; Athanasiou S; Chang J; Gruböck K; Ashley S; Oakes L; Tidy A; Davey J; Viggers J; Humphries S; Collins W
Br J Cancer; 1998 Jul; 78(2):272-5. PubMed ID: 9683306
[TBL] [Abstract][Full Text] [Related]
7. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
8. The effects of tamoxifen on the uterus.
Ismail SM
Curr Opin Obstet Gynecol; 1996 Feb; 8(1):27-31. PubMed ID: 8777254
[TBL] [Abstract][Full Text] [Related]
9. Sonohysterography for evaluation of the endometrium in women treated with tamoxifen.
Hann LE; Gretz EM; Bach AM; Francis SM
AJR Am J Roentgenol; 2001 Aug; 177(2):337-42. PubMed ID: 11461858
[TBL] [Abstract][Full Text] [Related]
10. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
11. Comparison of endometrial pathologies collected by hysteroscopy and hysterectomy in postmenopausal breast cancer tamoxifen-treated patients.
Cohen I; Azaria R; Bernheim J; Tepper R; Sharony R; Beyth Y
Eur J Gynaecol Oncol; 2000; 21(4):418-22. PubMed ID: 11055500
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of tamoxifen associated endometrial pathology in breast cancer patients.
Qureshi A; Bukhari F; Pervez S
J Pak Med Assoc; 2009 Apr; 59(4):249-50. PubMed ID: 19402291
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of hysteroscopic findings in breast cancer patients having adjuvant tamoxifen treatment.
Sendag F; Sahin C; Zeybek B; Terek MC; Oztekin K; Bilgin O
Eur J Gynaecol Oncol; 2010; 31(4):415-7. PubMed ID: 20882884
[TBL] [Abstract][Full Text] [Related]
15. Benign and hyperplastic endometrial changes associated with tamoxifen use.
Barakat RR
Oncology (Williston Park); 1997 Feb; 11(2 Suppl 1):35-7. PubMed ID: 9065925
[TBL] [Abstract][Full Text] [Related]
16. Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.
Garuti G; Cellani F; Centinaio G; Montanari G; Nalli G; Luerti M
Gynecol Oncol; 2006 Nov; 103(2):599-603. PubMed ID: 16750259
[TBL] [Abstract][Full Text] [Related]
17. Hysteroscopic dynamic assessment of the endometrium in patients treated with long-term tamoxifen.
Pérez-Medina T; Salazar FJ; San-Frutos L; Ríos M; Jiménez JS; Troyano J; Cayuela E; Iglesias E
J Minim Invasive Gynecol; 2011; 18(3):349-54. PubMed ID: 21411378
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
19. Continuous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies.
Cohen I; Tepper R; Rosen DJ; Shapira J; Cordoba M; Dror Y; Altaras M; Beyth Y
Gynecol Oncol; 1994 Oct; 55(1):138-43. PubMed ID: 7959255
[TBL] [Abstract][Full Text] [Related]
20. Endometrial changes with chronic tamoxifen use.
Loret de Mola JR
Curr Opin Obstet Gynecol; 1997 Jun; 9(3):160-4. PubMed ID: 9263698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
